Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

3.40
Delayed Data
As of May 25
 -0.10 / -2.86%
Today’s Change
2.10
Today|||52-Week Range
4.45
+58.14%
Year-to-Date

Today’s Trading

Previous close3.50
Today’s open3.21
Day’s range3.21 - 3.50
Volume25,287
Average volume (3 months)151,870
Market cap$84.5M
Dividend yield--
Data as of 3:49pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)+19.47%
Earnings growth (this year)+10.65%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
NVETNexvet Biopharma plc-0.01-0.11%
NOVNNovan Inc-0.11-2.23%
NNVCNanoViricides Inc+0.02+1.46%
BLRXBioLine RX Ltd-0.01-1.17%
Data as of 4:00pm ET, 05/25/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$57.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John D. Mendlein
Vice President-
Finance
John T. Blake
Corporate headquarters
San Diego, California

Forecasts